Medicamen Biotech has informed that it enclosed disclosure dated March 22, 2025 in Form-C pursuant to Regulation 7(2)(a) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 with respect to intimation received from Shivalik Rasayan for purchase of 21,000 Equity Shares from the open market.
The above information is a part of company’s filings submitted to BSE.